Tuesday 13 October 2026
Export NUS’s income statement to Excel — free account
Nu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.87
0.13
+2.74%
Follow NUS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (32.53%) | 7.04% | 22.00% | 14.55% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 7 | 7 | 6 | |
| (16.87%) | 3.94% | 11.15% | 7.29% | ||
ROIC |
(1.15%) | 6.09% | 5.21% | (0.85%) | |
Return on Tangible Assets |
(34.27%) | 8.42% | 24.23% | 16.38% | |
Average Days of Receivables |
12.98 | 11.40 | 9.72 | 11.44 | |
Free Cash Flow per Share |
0.22 | 0.86 | 0.93 | 1.08 | |
Free Cash Flow |
10.78 | 41.57 | 46.01 | 53.35 | |
Capital Expenditures |
(40.03) | (34.41) | (34.28) | (36.10) | |
| Other line items | |||||
Cash ROIC |
1.14% | 3.41% | 3.62% | 4.16% | |
Accounts Receivable Turnover |
25.33 | 28.37 | 32.88 | 26.51 | |
Accounts Payable Turnover |
12.76 | 14.18 | 14.86 | 16.71 | |
Inventory Turnover |
2.28 | 2.41 | 2.46 | 2.40 | |
Average Days of Payables |
32.48 | 23.77 | 21.06 | 20.34 | |
Days of Inventory on Hand |
164.94 | 147.36 | 143.70 | 127.32 | |
Tax Rate |
7.20 | (0.15) | (0.18) | (0.09) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
64.07% | 63.65% | 63.33% | 63.33% | |
Share Based Compensation of Revenue |
1.00% | 1.28% | 1.62% | 1.56% | |
Interest Coverage |
(0.66) | 5.34 | 4.71 | (0.67) | |
Operating CF/Net income |
(0.23) | 1.39 | 0.50 | 0.82 | |
Depreciation/Fixed assets |
0.13 | 0.13 | 0.14 | 0.15 | |
Capex/Depreciation |
(0.80) | (0.68) | (0.66) | (0.65) | |
Revenue per Share |
28.30 | 29.90 | 30.13 | 31.59 | |
Operating CF per Share |
1.05 | 1.58 | 1.63 | 1.81 | |
Capex per Share |
(0.82) | (0.71) | (0.70) | (0.73) | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.02 |
Columns are period end dates